Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

The American Parkinson Disease Association Awards $1.5 Million in Research Grants
  • USA - English


News provided by

American Parkinson Disease Association

Aug 16, 2017, 13:00 ET

Share this article

Share toX

Share this article

Share toX


NEW YORK, NY (PRWEB) August 16, 2017 -- With a new PD diagnosis every nine minutes, research is critical as we push for better treatments and ultimately, a cure.

There is an urgent need to accelerate research and support translational ideas that have the potential to truly improve the quality of life for people living with PD,

Post this

The grants are awarded through a competitive application process and reviewed by APDA’s Scientific Advisory Board (SAB) which is comprised of scientists with a wide array of backgrounds and expertise in all areas relevant to PD research. The SAB meets annually to review all grant proposals and set the scientific direction of APDA’s annual research investment. Their focus is to identify researchers early in their careers and attract them to the PD field, as well as to help established investigators pursue new and novel ideas. In many cases these projects produce significant pilot data, which has enabled researchers to apply for and receive multimillion dollar research grants from the National Institutes of Health and other funding institutions.

“There is an urgent need to accelerate research and support translational ideas that have the potential to truly improve the quality of life for people living with PD,” commented David G. Standaert, MD, PhD, John N. Whitaker Professor, Chair of Neurology at the University of Alabama at Birmingham, School of Medicine and Chairman of the SAB. “Now is a time of tremendous excitement in Parkinson’s research. The objective of the SAB is to invest in the best science that will move the field forward, to slow or cure the disease.”

APDA has been a funding partner in many of the significant Parkinson’s scientific discoveries in the last 50 years including the work of Dr. George C. Cotzias, which led to establishing the effectiveness of levodopa in treating PD; this treatment remains the gold standard in PD treatment today.

“The work being done as a result of the grants in this new funding cycle will have an incredible impact on the world of PD,” stated Leslie A. Chambers, President & CEO of APDA. “We are truly excited about the range of projects we are able to support - from neuroprotection that can slow the progress of the disease, to biomarkers which can help measure the activity of the disease, to novel ideas such as wearables and evidence-based non-medical therapies that can help improve quality of life. The questions posed by our researchers span a broad and exciting range of areas. This work is only possible because of the steadfast support of our generous APDA donors.”

Post-Doctoral Fellowships were awarded to support post-doctoral scientists whose research holds promise to provide new insights into pathophysiology, etiology and treatment of PD:

  • Xu Hou, PhD, Mayo Clinic, Jacksonville, FL
  • Md Shariful Islam, PhD, Van Andel Institute, Grand Rapids, MI
  • Isabel Lam, PhD, The Brigham and Women’s Hospital, Boston, MA
  • An Phu Tran Nguyen, PhD, Van Andel Institute, Grand Rapids, MI

Research Grants were awarded to investigators affiliated with and performing PD research at major academic institutions across the United States.

  • Joseph DeGutis, PhD, and Alice Cronin-Golomb, PhD, Boston University School of Medicine, Boston, MA
  • Xianjun Dong, PhD, The Brigham and Women’s Hospital, Boston, MA
  • Michael L. Gross, PhD, Washington University School of Medicine, St. Louis, MO
  • Andreas H. Kottmann, PhD, City College of New York, New York City, NY
  • Beom-Chan Lee, PhD, University of Houston, Houston, TX
  • Xiaobo Mao, PhD, Johns Hopkins University School of Medicine, Baltimore, MD
  • Ignacio F. Mata, PhD, Seattle Institute for Biomedical and Clinical Research, Seattle, WA
  • Rahul Srinivasan, PhD, Texas A&M Health Science Center, Bryan, TX
  • Yulan Xiong, PhD, Kansas State University, Manhattan, KS
  • Talene Yacoubian, MD, PhD, University of Alabama at Birmingham, School of Medicine, Birmingham, AL
  • Tonya Zeczycki, PhD, East Carolina University, Greenville, NC

APDA Centers for Advanced Research support large research programs which include research trainees, fellowship programs, early stage discovery programs and later stage clinical translation. These Centers facilitate research which is at the forefront of investigation into the cause, treatment and ultimately cure for PD.

  • Boston University School of Medicine, Boston, MA
  • David Geffen School of Medicine at UCLA Medicine, Los Angeles, CA
  • Emory University School of Medicine, Atlanta, GA
  • Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ
  • University of Alabama at Birmingham, School of Medicine, Birmingham, AL
  • University of Pittsburgh Medical Center, PA
  • University of Virginia Health System, Charlottesville, VA
  • Washington University School of Medicine, St. Louis, MO

Learn more about these grantees and the exciting work they are doing and browse all APDA funded research.

Stephanie Paul, American Parkinson Disease Association, http://www.apdaparkinson.org, +1 718-981-9202, [email protected]

Modal title

View PDF

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.